Long-term methylphenidate use for children and adolescents with attention deficit hyperactivity disorder and risk for depression, conduct disorder, and psychotic disorder: a nationwide longitudinal cohort study in South Korea

BACKGROUND: Methylphenidate (MPH) is the most frequently prescribed medication for the treatment of attention deficit hyperactivity disorder (ADHD). However, the safety of its long-term use remain unclear. In particular, real-world evidence of long-term MPH treatment regarding the risk of depression...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Jimyung, Lee, Dong Yun, Kim, Chungsoo, Lee, Yo Han, Yang, Su-Jin, Lee, Sangha, Kim, Seong-Ju, Lee, Jeewon, Park, Rae Woong, Shin, Yunmi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9554986/
https://www.ncbi.nlm.nih.gov/pubmed/36221129
http://dx.doi.org/10.1186/s13034-022-00515-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9554986/
https://www.ncbi.nlm.nih.gov/pubmed/36221129
http://dx.doi.org/10.1186/s13034-022-00515-5

Ejemplares similares